Overview Dividends

(CRBG) Corebridge Financial - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US21871X1090

Annuities, Life Insurance, Retirement Plans, Institutional Products

CRBG EPS (Earnings per Share)

EPS Growth (3Y CAGR): -17.07%
EPS Trend (3Y Correlation): -49.0%

CRBG Revenue

Revenue Growth (3Y CAGR): -56.35%
Revenue Trend (3Y Correlation): -54.5%

Description: CRBG Corebridge Financial

Corebridge Financial, Inc. (NYSE: CRBG) delivers retirement and insurance solutions across four segments: Individual Retirement (fixed, indexed, and variable annuities), Group Retirement (in-plan recordkeeping, flexible annuities, and advisory services), Life Insurance (term, whole, indexed universal, and guaranteed universal life), and Institutional Markets (stable-value wraps, pension-risk-transfer annuities, BOLI, and private-placement products). The firm, formerly SAFG Retirement Services, was incorporated in 1998 and is based in Houston, Texas.

Key operating metrics from the most recent FY 2023 filing show total revenue of approximately $2.1 billion, a net income of $210 million, and a combined ratio of 92.5% in the annuity business-indicating modest underwriting profitability. The segment most sensitive to macro-economic conditions is Individual Retirement, where rising interest rates have lifted the yields on fixed-index annuities but also increased the cost of guarantees, while longevity risk remains a primary driver for Life Insurance pricing. Institutional demand for stable-value wraps and pension-risk-transfer solutions has been buoyed by corporate cash-rich balance sheets seeking higher yields in a low-coupon environment.

For a deeper, data-driven view of CRBG’s valuation dynamics and scenario analysis, you may find the research tools on ValueRay worth exploring.

CRBG Stock Overview

Market Cap in USD	17,554m
Sub-Industry	Diversified Financial Services
IPO / Inception	2022-09-15

CRBG Stock Ratings

Growth Rating	73.9%
Fundamental	39.6%
Dividend Rating	56.0%
Return 12m vs S&P 500	-11.5%
Analyst Rating	4.07 of 5

CRBG Dividends

Dividend Yield 12m	3.10%
Yield on Cost 5y	5.75%
Annual Growth 5y	41.42%
Payout Consistency	71.0%
Payout Ratio	37.0%

CRBG Growth Ratios

Growth Correlation 3m	-84%
Growth Correlation 12m	63.7%
Growth Correlation 5y	91.8%
CAGR 5y	22.89%
CAGR/Max DD 3y (Calmar Ratio)	0.65
CAGR/Mean DD 3y (Pain Ratio)	2.57
Sharpe Ratio 12m	0.65
Alpha	-10.57
Beta	0.917
Volatility	31.87%
Current Volume	3568.1k
Average Volume 20d	3416.4k
Stop Loss	29.7 (-3%)
Signal	-0.57

Piotroski VR‑10 (Strict, 0-10) 1.0

Net Income (-337.0m TTM) > 0 and > 6% of Revenue (6% = 797.9m TTM)

FCFTA 0.00 (>2.0%) and ΔFCFTA -0.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 368.3% (prev 352.2%; Δ 16.13pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.00 (>3.0%) and CFO 1.68b > Net Income -337.0m (YES >=105%, WARN >=100%)

Net Debt (9.17b) to EBITDA (704.0m) ratio: 13.02 <= 3.0 (WARN <= 3.5)

Current Ratio 6.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (550.3m) change vs 12m ago -10.17% (target <= -2.0% for YES)

Gross Margin 95.77% (prev 98.43%; Δ -2.66pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 3.40% (prev 4.82%; Δ -1.41pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 0.75 (EBITDA TTM 704.0m / Interest Expense TTM 563.0m) >= 6 (WARN >= 3)

Altman Z'' 0.98

(A) 0.12 = (Total Current Assets 58.44b - Total Current Liabilities 9.46b) / Total Assets 399.16b

(B) 0.04 = Retained Earnings (Balance) 17.67b / Total Assets 399.16b

(D) 0.02 = Book Value of Equity 7.04b / Total Liabilities 385.99b

Total Rating: 0.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 39.60

1. Piotroski 1.0pt = -4.0

2. FCF Yield 7.32% = 3.66

3. FCF Margin 12.62% = 3.15

4. Debt/Equity 0.77 = 2.21

5. Debt/Ebitda 13.02 = -2.50

6. ROIC - WACC (= -4.75)% = -5.93

7. RoE -2.73% = -0.46

8. Rev. Trend -54.54% = -4.09

9. EPS Trend -49.02% = -2.45

What is the price of CRBG shares?

As of October 17, 2025, the stock is trading at USD 30.63 with a total of 3,568,098 shares traded.
Over the past week, the price has changed by -4.82%, over one month by -2.33%, over three months by -11.20% and over the past year by +1.59%.

Is Corebridge Financial a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Corebridge Financial (NYSE:CRBG) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 39.60 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRBG is around 30.15 USD . This means that CRBG is currently overvalued and has a potential downside of -1.57%.

Is CRBG a buy, sell or hold?

Corebridge Financial has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy CRBG.

Strong Buy: 6
Buy: 5
Hold: 2
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the CRBG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	40	30.6%
Analysts Target Price	40	30.6%
ValueRay Target Price	33.1	8%

Last update: 2025-10-16 02:29

CRBG Fundamental Data Overview

Market Cap USD = 17.55b (17.55b USD * 1.0 USD.USD)
P/E Forward = 5.9916
P/S = 1.0914
P/B = 1.4248
Beta = 0.917
Revenue TTM = 13.30b USD
EBIT TTM = 424.0m USD
EBITDA TTM = 704.0m USD
Long Term Debt = 11.25b USD (from longTermDebt, last quarter)
Short Term Debt = 9.46b USD (from shortTermDebt, last quarter)
Debt = 9.46b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.17b USD (from netDebt column, last quarter)
Enterprise Value = 22.91b USD (17.55b + Debt 9.46b - CCE 4.10b)
Interest Coverage Ratio = 0.75 (Ebit TTM 424.0m / Interest Expense TTM 563.0m)
FCF Yield = 7.32% (FCF TTM 1.68b / Enterprise Value 22.91b)
FCF Margin = 12.62% (FCF TTM 1.68b / Revenue TTM 13.30b)
Net Margin = -2.53% (Net Income TTM -337.0m / Revenue TTM 13.30b)
Gross Margin = 95.77% ((Revenue TTM 13.30b - Cost of Revenue TTM 563.0m) / Revenue TTM)
Gross Margin QoQ = 81.41% (prev 95.88%)
Tobins Q-Ratio = 0.06 (Enterprise Value 22.91b / Total Assets 399.16b)
Interest Expense / Debt = 1.45% (Interest Expense 137.0m / Debt 9.46b)
Taxrate = -9.87% (negative due to tax credits) (60.0m / -608.0m)
NOPAT = 465.8m (EBIT 424.0m * (1 - -9.87%)) [negative tax rate / tax credits]
Current Ratio = 6.18 (Total Current Assets 58.44b / Total Current Liabilities 9.46b)
Debt / Equity = 0.77 (Debt 9.46b / totalStockholderEquity, last quarter 12.30b)
Debt / EBITDA = 13.02 (Net Debt 9.17b / EBITDA 704.0m)
Debt / FCF = 5.46 (Net Debt 9.17b / FCF TTM 1.68b)
Total Stockholder Equity = 12.34b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.08% (Net Income -337.0m / Total Assets 399.16b)
RoE = -2.73% (Net Income TTM -337.0m / Total Stockholder Equity 12.34b)
RoCE = 1.80% (EBIT 424.0m / Capital Employed (Equity 12.34b + L.T.Debt 11.25b))
RoIC = 1.91% (NOPAT 465.8m / Invested Capital 24.36b)
WACC = 6.66% (E(17.55b)/V(27.01b) * Re(9.39%) + D(9.46b)/V(27.01b) * Rd(1.45%) * (1-Tc(-0.10)))
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.76%
[DCF Debug] Terminal Value 74.72% ; FCFE base≈2.26b ; Y1≈2.44b ; Y5≈2.99b
Fair Price DCF = 76.52 (DCF Value 41.21b / Shares Outstanding 538.5m; 5y FCF grow 8.53% → 3.0% )
EPS Correlation: -49.02 | EPS CAGR: -17.07% | SUE: -1.32 | # QB: 0
Revenue Correlation: -54.54 | Revenue CAGR: -56.35% | SUE: -0.41 | # QB: 0

Additional Sources for CRBG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle